Rare diseases
Investigational molecules
Locations
Back to France807 clinical trials in Dijon, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Itacitinib for Adults with Diffuse Systemic Sclerosis
FranceStudy of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
FranceStudy Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer
FranceStudy on Apalutamide with Radiotherapy and Hormone Therapy for High-Risk Prostate Cancer Patients with Rising PSA After Surgery
FranceStudy on the Safety of Lutetium (177Lu) Oxodotreotide with Arginine and Lysine in Children with Refractory or Recurrent Neuroblastoma
FranceStudy on Gemtuzumab Ozogamicin and Gilteritinib for Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
FranceStudy of Lacutamab, Gemcitabine, and Oxaliplatin for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
FranceStudy Comparing Sentinel Node Policy with Current Staging Protocols in Early Stage Endometrial Cancer Using Patent Blue, Technetium (99mTc) Rheniumsulfide, and Indocyanine Green
FranceStudy on the Safety and Immune Response of Meningococcal B Vaccines in Adults with Asplenia: Bexsero, Trumenba, and a Drug Combination
FranceFranceStudy on the Effects of ISIS 678354 in Patients with Familial Chylomicronemia Syndrome (FCS)
FranceStudy of Ceralasertib for Patients with Advanced Cancer with Molecular Changes
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for head and neck cancer, gastric cancer, and multiple types of lung cancer. Research encompasses novel therapeutic approaches and targeted treatments.
Several studies are evaluating new combination therapies and immunotherapy approaches for better treatment outcomes.
Research focusing on immune system responses and vaccine development, with particular emphasis on COVID-19 prevention and treatment strategies. Studies include innovative approaches to boosting immunity.
Trials are investigating both intranasal and traditional vaccination methods for optimal immune response.
Studies focusing on heart disease management and prevention, including innovative treatments for acute myocardial infarction and heart failure prevention strategies.
Research includes novel pain management approaches and preventive treatments for cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
